herpes%20simplex%20virus%20infection
HERPES SIMPLEX VIRUS INFECTION
Primary herpes simplex virus (HSV) infection is first infection with either herpes simplex virus-1 (HSV-1) or herpes simplex virus-2 (HSV-2) in individuals who do not have antibodies to either HSV-1 or HSV-2.
First episode-non primary infection is infection with either HSV-1 or HSV-2 in individuals who have previously existing antibodies against HSV-1 or HSV-2 respectively.
Recurrent HSV infection results from reactivation of latent virus. It is usually brought about by triggering factors eg UV light, immunosuppression.
Orolabial HSV disease is mostly caused by HSV-1 that occurs most commonly in children <5 years of age. It is transmitted through close contact with individuals who have active viral shedding.
Genital HSV disease is caused by HSV-2 that is the usual cause of herpes genitalis. It typically occurs in adults and transmitted through sexual contact.
Drug Information

Indication: Short-term local treatment of pain associated w/ sore throat in nonpurulent infections.

Indication: Herpes zoster. Reduces duration & proportion of patients w/ zoster-associated pain, which includes acute &...

Indication: Herpes simplex & varicella zoster infections; herpes simplex prophylaxis in immune-compromised patients.

Indication: Herpes simplex & varicella zoster infections. Herpes simplex infection prophylaxis in immunocompromised pa...

Indication: Varicella-zoster viral infections. Skin & mucous membrane infections due to herpes simplex virus. Prophyla...

Indication: Herpes simplex virus, varicella & herpes zoster infections. Suppression & prophylaxis of herpes simple...

Indication: Treatment & suppression of herpes simplex infection. Prophylaxis of herpes simplex infection in immunocomp...

Indication: Herpes simplex & varicella zoster infection. Prophylaxis of herpes simplex infection in immunocompromised ...

2  /  3
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 06 Aug 2019
The guideline-recommended, single-tablet, fixed-dose regimen comprising bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) was noninferior to the dolutegravir and F/TAF (D/F/TAF) regimen in persons living with HIV (PLHIV), according to data presented at IAS 2019.